Six months after the introduction of hemodialysis, the patient developed pyelonephritis and his PR3-ANCA level increased from 5.1 U/mL to 88.6 U/mL (reference range: <3.5 U/mL). The gene discussed is PRTN3; the disease is pyelonephritis.